These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21420381)

  • 1. Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
    Liu YH; Ho CC; Cheng CC; Chao WT; Pei RJ; Hsu YH; Lai YS
    Biochem Biophys Res Commun; 2011 Apr; 407(3):575-80. PubMed ID: 21420381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis.
    Liu YH; Cheng CC; Ho CC; Chao WT; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
    In Vivo; 2008; 22(5):543-8. PubMed ID: 18853744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
    Liu YH; Cheng CC; Lai YS; Chao WT; Pei RJ; Hsu YH; Ho CC
    Biochem Biophys Res Commun; 2011 Jan; 404(1):488-93. PubMed ID: 21144834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphism of cancer cells with the expression of plectin and concept of filament bundles in human hepatocellular carcinoma.
    Liu YH; Ho CC; Cheng CC; Pei RJ; Hsu YH; Yeh KT; Tsai MC; Lai YS
    Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):43-54. PubMed ID: 21469503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro.
    Liu YH; Cheng CC; Ho CC; Chao WT; Pei RJ; Hsu YH; Ho LC; Shiu BH; Lai YS
    Med Mol Morphol; 2011 Mar; 44(1):21-6. PubMed ID: 21424933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.
    Cheng CC; Liu YH; Ho CC; Chao WT; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
    J Mol Histol; 2008 Apr; 39(2):209-16. PubMed ID: 18038249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Pleomorphism and Cytoskeleton Disorganization in Human Liver Cancer.
    Cheng CC; Lai YC; Lai YS; Chao WT; Tseng YH; Hsu YH; Chen YY; Liu YH
    In Vivo; 2016 09-10; 30(5):549-55. PubMed ID: 27566071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered synemin could affect the organization of intermediate filament in human hepatocellular carcinoma.
    Ho CC; Ho HC; Liu YH; Pei RJ; Cheng CC; Lee KY; Yeh KT; Lai YS
    J Med; 2004; 35(1-6):171-80. PubMed ID: 18084875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of plectin and intermediate filaments.
    Karashima T; Tsuruta D; Hamada T; Ishii N; Ono F; Hashikawa K; Ohyama B; Natsuaki Y; Fukuda S; Koga H; Sogame R; Nakama T; Dainichi T; Hashimoto T
    J Dermatol Sci; 2012 Apr; 66(1):44-50. PubMed ID: 22333906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review.
    Lai YC; Cheng CC; Lai YS; Liu YH
    Cancer Genomics Proteomics; 2017; 14(4):219-223. PubMed ID: 28647696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorganization of microfilaments and intermediate filaments interferes with the assembly and stability of desmosomes in MDCK epithelial cells.
    Pasdar M; Li Z
    Cell Motil Cytoskeleton; 1993; 26(2):163-80. PubMed ID: 8287501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.
    Ho CC; Cheng CC; Liu YH; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
    In Vivo; 2008; 22(4):457-62. PubMed ID: 18712172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL.
    Giuliano M; Bellavia G; Lauricella M; D'Anneo A; Vassallo B; Vento R; Tesoriere G
    Int J Mol Med; 2004 Apr; 13(4):565-71. PubMed ID: 15010857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma.
    Lee KY; Liu YH; Ho CC; Pei RJ; Yeh KT; Cheng CC; Lai YS
    J Med; 2004; 35(1-6):141-9. PubMed ID: 18084872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diode 808 nm GaAlAs low-power laser irradiation on inhibition of the proliferation of human hepatoma cells in vitro and their possible mechanism.
    Liu YH; Cheng CC; Ho CC; Pei RJ; Lee KY; Yeh KT; Chan Y; Lai YS
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():185-201. PubMed ID: 17564317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of Bcl-xL in human hepatocellular carcinomas.
    Takehara T; Liu X; Fujimoto J; Friedman SL; Takahashi H
    Hepatology; 2001 Jul; 34(1):55-61. PubMed ID: 11431734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest.
    Presland RB; Kuechle MK; Lewis SP; Fleckman P; Dale BA
    Exp Cell Res; 2001 Nov; 270(2):199-213. PubMed ID: 11640884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plectin controls biliary tree architecture and stability in cholestasis.
    Jirouskova M; Nepomucka K; Oyman-Eyrilmez G; Kalendova A; Havelkova H; Sarnova L; Chalupsky K; Schuster B; Benada O; Miksatkova P; Kuchar M; Fabian O; Sedlacek R; Wiche G; Gregor M
    J Hepatol; 2018 May; 68(5):1006-1017. PubMed ID: 29273475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
    Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
    Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.